Document is current
Any future updates will be listed below
-
Authors
Romijnders, Kim A. G. J. https://orcid.org/0000-0002-1491-3826
Romero Gonzalez, Franco https://orcid.org/0009-0008-4509-8060
Matser, Amy
Verburgh, Myrthe L.
Dijkstra, Maartje
Reiss, Peter https://orcid.org/0000-0001-7896-6428
Kretzschmar, Mirjam https://orcid.org/0000-0002-4394-7697
Nieuwkerk, Pythia
Schim van der Loeff, Maarten https://orcid.org/0000-0002-4903-7002
Basten, Maartje https://orcid.org/0000-0001-9982-7048
Rozhnova, Ganna https://orcid.org/0000-0002-6725-7359
-
Funding
Funding for this research was provided by:
Aids Fonds (P-52901, P-52901)
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 7 April 2025
First Online: 3 May 2025
Competing interests
: The authors declare competing interests for: The institution of M. F. Schim van der Loeff received study funding from GSK; he served on advisory boards of GSK and Merck. P.R. has received grant support from Gilead Sciences, ViiV Healthcare, and Merck & Co. G.R. is an Editorial Board Member of Communications Medicine, but was not involved in the editorial review or peer review, nor the decision to publish this article. The other authors have no competing interests to disclose.
